Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cyclin-dependent kinase-like 2 is a CDC2-related serine/threonine protein kinase encoded by the CDKL2 gene in humans. The protein accumulates primarily in the cytoplasm, with lower levels detected in the nucleus. It is classified as part of a large family of protein kinases structurally related to cyclin-dependent kinases but is considered a distinct entity. While it possesses protein kinase activity, specific biological functions and disease associations are less well-characterized compared to classical CDKs such as CDK1 or CDK2. CDKL2 is not synonymous with CDK2 or classical cyclin-dependent kinases, though they share similarity in sequence and domain architecture. The correct canonical name is Cyclin-dependent kinase-like 2 (CDKL2). It is an enzyme, specifically a serine/threonine kinase, belonging to the CDC2-related protein kinase family. Its biological role is phosphorylation of protein substrates, potentially affecting cellular signaling and possibly cell cycle regulation, but the specifics are not well established in public domain sources. There are no reported drugs, biomarkers, or major toxicology concerns linked to CDKL2 as of the information available in current search results.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cyclin-dependent kinase-like 2 (CDKL2).